Clusi Pharma, UAB
Copy
CopyCompany details
Legal status
ActiveCompany ID
307404023Copy
CopyVAT code
Not registered
Incorporation date
26/08/2025Company's manager/representative
Justina Krukonytė-Racz, DirectorCopy
CopyShare capital
1,000.00 EURContacts
Company registration address
Vilnius, Kalvarijų g. 125, LT-08221Check the map
Copy
Pre-Score is a statistical predictive model developed by our partner, SCORIFY, based on open data about legal entities. Pre-Score predicts the probability of a company's bankruptcy within next 12 months. Based on all available data about the company (not only open data), the probability of default is estimated by SCORIFY's GOscore rating, which can be found in credit report.Important: The Pre-Score is an opinion of SCORIFY, expressed by using a defined and specified assessment scale. SCORIFY's opinion is not necessarily the same as the opinion of creditors or the company's about its financial reliability.
More about SCORIFY www.scorify.ai
C
AverageHighest reliabilityLowest reliability
Reliability
A - Highest
B - High
C - AverageD - Low
E - Lowest
Fair Business loans
Borrow for business up to 50 000 € without collateralApply for a loan
Data on insured persons (natural persons) whose state social insurance commencement has been notified by the employer to the SSIFB.More information: www.sodra.lt
Number of employees
2
+2 ** during past year
The average wage - the amount of wages or other income on which social security contributions are paid. This data is disclosed only if company has more than 3 employees.Average wage
No data available
0 € ** during past year
Debts
810.46 €
+810.46 € ** during past year
0 %Turnover
0 €Credit report
25
Data sourcesBusiness linkages
1
LinkageMonitoring
12
Changes during the yearSimilar companies
1489
Similar companiesThe value of a company is calculated by our partner UAB SCORIFY and is based on Excess return model. It measures the ability of business to generate value added profit in both - short and long term.The calculations of Escess return model use main profitability and growth ratios, that are also assessed by analyzing company`s financial state.
Company`s value helps:
- Find out if your business has paid off.
- Compare the value of your, competitor`s or business partners companies.
- Strengthen the negotiating position in case of purchase or sale of the company.
More about SCORIFY www.scorify.ai
Company's value
Enjoy unlimited use
with Freemium unlimitedCredit limit is a product of our partner, credit risk assessment and artificial intelligence professional company SCORIFY. The credit limit calculation is based on financial statement data provided by company to Register of Legal Entities and statistical credit risk assessment model of GO score - UAB SCORIFY. Main financial ratios used in calculation of credit limit are:
- Tangible assets.
- Working capital.
- Sales.
- Efficiency ratios.
- Profitability ratios.
- Liquidity ratios.
Credit limit will help you:
- Preliminary assess your credit options before applying for a loan or buying a assets by lease (eg equipment or a car).
- Quickly and easily assess the financial capabilities of business partners by selling them goods or services on deferred payment.
More about SCORIFY www.scorify.ai
Credit limit
EstimatedRelated persons
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Justina Krukonytė-Racz | Director | 26/08/2025 | present | 1 |
Financial ratios
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimited
| Indicator |
|---|
| Turnover (€)From 2022 the financial data of public bodies, associations and charities and support funds shows the total income, which is the sum of sales income, financing income and all other income. |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirementThe working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2024 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2025 |
|---|
| 0 |
| 0 |
| -2,249 |
| -2,249 |
| -2,249 |
| - |
| - |
| -1,249 |
| 2,249 |
| 0 |
| 1,000 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 0 |
| 0 |
| -2,249 |
| -2,249 |
| -2,249 |
| - |
| - |
| -1,249 |
| 2,249 |
| 0 |
| 1,000 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
0 €
- *
Sales per employee (€)
0 €- *
Profit before tax (€)
-2,249 €- *
Net Profit (€)
-2,249 €- *
Profit per employee (€)
-2,249 €- *
Total profitability (%)
-Net profitability (%)
-Equity (€)
-1,249 €- *
Amounts Payable And Liabilities (€)
2,249 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
1,000 €- *
Credit history
No. of unpaid debts
Enjoy unlimited use
with Freemium unlimitedAmount of unpaid debts
Enjoy unlimited use
with Freemium unlimitedCredit report
Price: €35.99 | 1.00 credit
Company has debt ?
No. of unpaid debts
1
Largest debt
SODRA
Amount of unpaid debts
€810.46
Oldest open debt
-
Unpaid debts
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Debts payment history
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
|---|---|---|---|
- | - | - | - |
Tax debtsSODRA debt is the amount of national social security contributions, fines, late payment penalties and interest that company should have been paid in accordance with the legislation 2 working days before the date of debt public disclosure. Deferred debt is a debt for which the due date has been postponed in accordance with the procedure provided for by law and has not yet expired. Debts is updated only on working days, except for the first working day after the public holiday.
SODRA debt is the amount of national social security contributions, fines, late payment penalties and interest that company should have been paid in accordance with the legislation 2 working days before the date of debt public disclosure. Deferred debt is a debt for which the due date has been postponed in accordance with the procedure provided for by law and has not yet expired. Debts is updated only on working days, except for the first working day after the public holiday.
Sodra debt
STI debtCourts
Defendant
(0)
Plaintiff
(0)
3rd party
(0)
Clusi Pharma, UAB has no court cases
Clusi Pharma, UAB has no registered court cases as defendant or plaintiff within the last 2 years.
ESG data
Energy performance of the company's head office building
Information is provided on the basis of public data about building energy efficiency certification published by State Agency of Construction Sector Development.More information: https://www.ssva.lt
Energy efficiency
F
AddressVilnius, Kalvarijų g. 125, LT-08221
Certificate No.GM-0163-01063
Date of issue31/08/2021
Valid till31/08/2031
Heated area136.09 m²
Heat sourceŠil.įrenginys_1: Šilumos tinklai + pastato šilumos punktas
Energy consumptionEnergy consumption (kWh/m²/year) - Calculated total energy consumption per square metre of the useful floor area of a building (part of a building).
0 kWh/m²/metaiEnergy consumption (kWh/m²/year) - Calculated total energy consumption per square metre of the useful floor area of a building (part of a building).Co2 emissionCO₂ - the annual carbon dioxide emissions of a building (part of a building).
25.28 kg/m²/metaiCO₂ - the annual carbon dioxide emissions of a building (part of a building).Energy consumption for heating
130.52 kWh/m²/metaiBuilding function
Garažų, gamybos ir pramonės paskirties pastataiEnergy effiency class
FClusi Pharma, UAB has no registered vehicles
No vehicles are registered under Clusi Pharma, UAB as owner-operator.
Browse companies with registered vehiclesTrademarks
Clusi Pharma, UAB has no registered trademarks
Clusi Pharma, UAB has not registered any trademarks in Lithuania.
Public data
Govermental support
Institution | Support measure |
|---|---|
 | Subsidies to preserve work places |
| Subsidies for downtime in 2020 |
 | ILTE business promotion measures (subsidies, compensations) in 2020 |
| ILTE business promotion measures (guarantees provided) in 2020 |
| ILTE business promotion measures (guarantees provided) in 2021 |
Enjoy unlimited use
with Freemium unlimitedPublic negative information
Data source | Information |
|---|---|
| Redundancy of employees group (number of employees notified, date of announcement) |
 | Tax inspectorate information on payments in cash |
 | Public procurement office information on unreliable suppliers |
| Public procurement office information on those that supplied false data |
| Public procurement office information on possible disqualification from public procurement procedures |
Enjoy unlimited use
with Freemium unlimitedPublic data
Data source | Information |
|---|---|
 | Data from the B2Lithuania database of exporters |
| The biggest taxpayers in 2021 |
| Top taxpayers in 2021 excluding excise duties and VAT. |
| Top personal income tax payers in 2021 |
| Top taxpayers for corporate income tax in 2021 |
Enjoy unlimited use
with Freemium unlimitedLicenses
Clusi Pharma, UAB has no licenses or permits
Clusi Pharma, UAB has no records of any licenses, permits, certificates, or other licensing documents issued.
Public procurement
No. of won tenders
0* during past yearTotal value of contracts
0 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Won tenders
Date | Procurer/contractor | Amount | Project |
|---|---|---|---|
- | - | - | - |
Announced tenders
Date | Procurer/contractor | Amount | Project |
|---|---|---|---|
- | - | - | - |
Archive of articles
Clusi Pharma, UAB has no press articles
Clusi Pharma, UAB has not been mentioned in any press articles in our database.
BNS News
0
Enjoy unlimited use
with Freemium unlimitedSimilar companies
1489
Category:
Wholesale of pharmaceutical and medical goodsComp. code:
307430580Reg. date:
15/09/2025Turnover:
No incomesNo. of employees:
1Category:
Wholesale of pharmaceutical and medical goodsComp. code:
307241081Reg. date:
01/07/2025Turnover:
No incomesNo. of employees:
1Category:
Wholesale of pharmaceutical and medical goodsComp. code:
307164610Reg. date:
05/05/2025Turnover:
No incomesNo. of employees:
1Category:
Wholesale of pharmaceutical and medical goodsComp. code:
307185113Reg. date:
27/05/2025Turnover:
No incomesNo. of employees:
4Category:
Wholesale of pharmaceutical and medical goodsComp. code:
307089474Reg. date:
06/02/2025Turnover:
No incomesNo. of employees:
2Description
CopyAbout Clusi Pharma, UAB
Clusi Pharma, UAB has been active for less than two years and was established in 26/08/2025, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Wholesale of pharmaceutical and medical goods (46.46.00 - EVRK 2.1), 46.46.00. Company's representation right – Sole representation.
In 2025 Clusi Pharma, UAB turnover was 0 EUR, gross profit -2,249 EUR. According to SODRA company has 2 employees. Clusi Pharma, UAB is registered at – Vilnius, Kalvarijų g. 125, LT-08221.
Business objectives of the company as officially recorded in the Register of Legal Entities: Kitų maisto produktų mažmeninė prekyba;
Kitų maisto produktų didmeninė prekyba;
Farmacinių preparatų gamyba;
Farmacijos prekių mažmeninė prekyba;
Farmacijos ir medicinos prekių didmeninė prekyba;
Teisinė veikla;
Konsultacinė verslo ir kito valdymo veikla.
(no translation available)
All data about Clusi Pharma, UAB is up to date and consistent with the primary data source.
Frequently Asked Questions
What is Clusi Pharma, UAB activity?
Clusi Pharma, UAB operates in wholesale of pharmaceutical and medical goods (46.46.00 - evrk 2.1).
Who is the manager of Clusi Pharma, UAB?
The manager of Clusi Pharma, UAB is Justina Krukonytė-Racz (Director).
What is Clusi Pharma, UAB company code?
Clusi Pharma, UAB company code is 307404023.
Is Clusi Pharma, UAB a reliable company?
Clusi Pharma, UAB Pre-Score* rating is C, which indicates a medium level of reliability.
* Pre-Score is a statistical prediction model developed by our partner SCORIFY, based on open company data. It predicts the probability of bankruptcy within the next 12 months. Based on all available data (not only open data), the probability of fulfilling obligations is calculated by SCORIFY GOscore, which is available in the company's credit report.How many employees does Clusi Pharma, UAB have?
Clusi Pharma, UAB has 2 employees (2026-06-24).
What is Clusi Pharma, UAB registered address?
Clusi Pharma, UAB registered address is Vilnius, Kalvarijų g. 125, LT-08221.
Does Clusi Pharma, UAB have debts?
Tax debt: 0.00 EUR, Social security debt: 810.46 EUR.